AMANDA VANCONANT: Open Payments
NPI 1477114890 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 10 payments from 6 companies in 2025. Trend: 2023 $324 · 2024 $176 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Vertical Pharmaceuticals, LLC | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: Auvelity, CAPLYTA, Relexxii, COBENFY, AUSTEDO XR, Jornay PM.
Industry payments across CO — which companies pay providers there.
